NCT00190918View on ClinicalTrials.gov

A Trial for Patients With Gestational Trophoblastic Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

July 31, 2007

Conditions
Trophoblastic NeoplasmsUterine NeoplasmsHydatidiform MoleChoriocarcinoma
Interventions
DRUG

Pemetrexed

Trial Locations (1)

Unknown

Gynecologic Oncology Group 215-854-0770, Philadelphia

All Listed Sponsors
collaborator

Gynecologic Oncology Group

NETWORK

lead

Eli Lilly and Company

INDUSTRY

NCT00190918 - A Trial for Patients With Gestational Trophoblastic Disease | Biotech Hunter | Biotech Hunter